PURE Bioscience Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	-3.96	-3.5	-2.32	-0.01	-6.56	-7.48	-6.52	-21.69	-7.61	-12.95	Upgrade
Depreciation & Amortization	0.12	0.21	0.17	0.19	0.24	0.29	0.28	0.22	0.21	0.25	Upgrade
Share-Based Compensation	0.32	0.57	0.84	0.79	2.45	2.36	1.07	1.9	2.38	2.96	Upgrade
Other Operating Activities	0.24	0.3	0.14	-0.3	0.88	0.94	0.61	14.57	-1.04	3.42	Upgrade
Operating Cash Flow	-3.28	-2.42	-1.17	0.67	-2.99	-3.89	-4.56	-4.99	-6.06	-6.33	Upgrade
Capital Expenditures	-0.03	-0.08	-0.52	-0.06	-0.01	-0.03	-0.23	-0.41	-0.11	-0.11	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-	0.07	Upgrade
Investing Cash Flow	-0.03	-0.08	-0.52	-0.06	-0.01	-0.03	-0.23	-0.41	-0.11	-0.05	Upgrade
Common Stock Issued	0	3.5	0	2.83	1.71	0.05	1.05	8	7.4	6.62	Upgrade
Other Financing Activities	1.02	-	0.24	-	0.84	3.08	0.19	1.27	0	-0.19	Upgrade
Financing Cash Flow	1.02	3.5	0.24	2.83	2.55	3.13	1.23	9.27	7.41	6.43	Upgrade
Net Cash Flow	-2.3	1	-1.45	3.44	-0.45	-0.79	-3.55	3.87	1.24	0.05	Upgrade
Free Cash Flow	-3.31	-2.5	-1.69	0.61	-3	-3.92	-4.79	-5.4	-6.17	-6.44	Upgrade
Free Cash Flow Margin	-176.40%	-134.86%	-42.98%	8.83%	-157.31%	-221.03%	-261.50%	-418.62%	-846.36%	-1170.55%	Upgrade
Free Cash Flow Per Share	-0.03	-0.03	-0.02	0.01	-0.04	-0.06	-0.08	-0.09	-0.16	-0.25	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.